Delisting riskPopularity #3,792
MDCX · NASDAQ · Biotechnology

Medicus Pharma (MDCX)

Develops clinical-stage therapies for skin cancer, urology, oncology, and women’s health.

$0.1578
vs last close−0.01 (−3.78%)

Something off on this page? Send us feedback.

Next report
Nov 13, 26
estimated · in 51 days
EPS estimate
−$0.17
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.18−$0.42−$0.43−$1.12−$0.51−$0.31−$0.21Pending
Estimate−$0.32−$0.23−$0.39−$0.38−$0.32−$0.18−$0.13−$0.17
Surprise+43.8%−82.6%−10.3%−194.7%−57.8%−72.2%−64.7%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
ReportedPending
Estimate
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2028$0.01
Sep 2028$0.01
Jun 2028$0.01
Mar 2028$0.01
Dec 2027−$0.02
Sep 2027−$0.02
Jun 2027−$0.02
Mar 2027−$0.02
Dec 2026−$0.11
Nov 2026−$0.17
Aug 2026−$0.13−$0.21−64.7%
May 2026−$0.18−$0.31−72.2%
Mar 2026−$0.32−$0.51−57.8%
Nov 2025−$0.38−$1.12−194.7%
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Nov 2023
Sep 2023
Jun 2023

The latest year is open to everyone — the 9 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2028$0.01$16.3M
Sep 2028$0.01$15.7M
Jun 2028$0.01$15.7M
Mar 2028$0.01$15.0M
Dec 2027−$0.02$0
Sep 2027−$0.02$0
Jun 2027−$0.02$0
Mar 2027−$0.02$0
Dec 2026−$0.11$0
Nov 13, 2026−$0.17$0
Aug 12, 2026−$0.13−$0.21−64.7%+6.9%
May 14, 2026−$0.18−$0.31−72.2%+5.3%
Mar 25, 2026−$0.32−$0.51−57.8%+1.0%
Nov 14, 2025−$0.38−$1.12−194.7%−2.7%
Aug 11, 2025
May 12, 2025
Mar 28, 2025
Nov 22, 2024
Aug 22, 2024
May 30, 2024
Nov 29, 2023
Sep 30, 2023
Jun 30, 2023

The latest year is open to everyone — the 9 quarters behind it read with an account.